DOTA-NAPamide

• UNSPSC Description:

  DOTA-NAPamide is a radionuclide conjugate (RDC), which is capable of binding to a radionuclide. RDC has the ability to specifically target biomolecules and can be used in medical imaging or therapy[1].

• Target Antigen:

  Others

• Type:

  Peptides

• Related Pathways:

  Others

• Field of Research:

  cancer

• Assay Protocol:

  https://www.medchemexpress.com/dota-napamide.html

• Smiles:

  CCCC[C@H](NC(C)=O)C(N[C@@H](CC(O)=O)C(N[C@@H](CC1=CN=CN1)C(N[C@H](CC2=CC=CC=C2)C(N[C@@H](CCCNC(N)=N)C(N[C@H](C(NCC(N[C@H](C(N)=O)CCCCNC(CN3CCN(CCN(CCN(CC3)CC(O)=O)CC(O)=O)CC(O)=O)=O)=O)=O)CC4=CNC5=CC=CC=C45)=O)=O)=O)=O)=O

• Molecular Weight:

  1485.64

• Shipping Conditions:

  Room temperature

• Clinical Information:

  No Development Reported

• CAS Number:

  935886-72-9